Feb 12, 2024
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
Jan 31, 2024
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024
Jan 04, 2024
PolyPid Announces Private Placement for $16 Million in Gross Proceeds
Displaying 21 - 23 of 23